AstraZeneca Share Price (AZN)

5,934.00 0.00 (0.00%) delayed: 4:47AM BST
Bid price 5,934.00 Open price 5,902.00
Ask price 5,935.00 Prev close 5,934.00
High price 0.00 Spread 0.02%
Low price 0.00 Volume 0

Register now for FREE live AstraZeneca share prices, AstraZeneca stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get AstraZeneca Level 2 Data, indepth research tools and investor commentary for AstraZeneca (AZN) and other London Stock Exchange equities.

AstraZeneca Share Price Chart

Advanced Charts >>

Register now for FREE AstraZeneca share price charts

AstraZeneca Share Price Information

Name AstraZeneca Epic AZN
Sector Pharmaceuticals & Biotechnology ISIN GB0009895292
Activites AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Index n/a

AstraZeneca Key Numbers

Latest Share Price (p) 5,934.00 Net Gearing (%) 68.49
Market Capitalisation (£m) 74,233.60 Gross Gearing (%) 73.73
Shares in issue (m) 1,266.78 Debt Ratio 64.57
P/E Ratio 24.73 Debt-to-Equity Ratio 0.65
Total dividends per share (p) 202.50 Assets / Equity Ratio 3.81
Dividend Yield (%) 3.45 Price to book value 4.46
Dividend cover (x) 1.17 ROCE (%) 4.74
Earning per share (p) 237.00 EPS Growth (%) -14.44
52 week high / low 6,122.00 / 4,544.50 DPS Growth (%) -7.49

AstraZeneca Director Deals

Dec.Date Type Director Pos No. of Shares
28/03/2018 TIN Pascal Soriot CEO 11,998
28/03/2018 TIN Marc Dunoyer FD 3,768
05/02/2018 BUY Philip Broadley NED 415
15/12/2017 TOUT Pascal Soriot CEO 39,648
28/07/2017 BUY Philip Broadley NED 2,300

More AstraZeneca Director Deals >>

AstraZeneca Company News

13:43 19/10/2018

AstraZeneca respiratory disease treatment endorsed by EU

AstraZeneca said European regulators had adopted a positive opinion of a treatment for chronic obstructive pulmonary disease. Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency had recommended marketing authorisation for Bevespi Aerosphere in a pressurised...

13:09 19/10/2018

CHMP positive opinion Bevespi Aerosphere

RNS Number : 6420E AstraZeneca PLC 19 October 2018   19 October 2018 13:00 BST CHMP issues a positive opinion for Bevespi Aerosphere  for the treatment of chronic obstructive pulmonary disease   AstraZeneca today announced that the Committee for Medicinal...

07:28 16/10/2018

AstraZeneca cancer treatment receives orphan drug designation from FDA

AstraZeneca said it and partner Merck had been granted an orphan drug designation by the FDA for their pancreatic cancer treatment. The use of pancreatic cancer treatment Lynparza was being assessed in an ongoing trial. The trial was testing the efficacy of Lynparza as a solo treatment...

More AstraZeneca Company News >>

Register now for FREE AstraZeneca company news

AstraZeneca Share Price Discussions

1 months ago

Any views on Astrazeneca (AZN)

Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

more than 1 year ago

Two Peaches!!!! (AZN)

(option stock price + price paid) (stock option sell price chnge on day for option) LOG MAY 280 PUT 23+6 263 24 AZN MAY 2600 PUT 104+25 2548 118 THESE WILL MOVE QUICKLY!

more than 1 year ago

FTSE signals (AZN)

FTSE 100 :4410.7+25 @16:36 MAIN S/R 4518 TARGET 4375/1 MINI S/R 4446 TARGET 4357/1 VOL 2850 YIELD 3.26 BAROMETER 32 LONG FTSE FUTURE (JUN 04) ARE @ 4423, 13 POINTS ABOVE CASH AND 1.5 ABOVE FAIR VALUE OF +11.5 DOW @ 10396+39 @ 17:00 (PUT YOUR SHORTS ON!!)

Register now for FREE AstraZeneca share price discussions